For 2007, the WHO estimated 511,000 cases of multidrug-resistant (MDR)-TB, representing approximately 5% of all TB cases worldwide. Extensively drug-resistant (XDR-TB) strains have been detected in at ...
Tufts University researchers’ approach uncovers how TB treatments can best work together at the cellular level to speed better cures Tuberculosis (TB) is the world’s deadliest infectious disease—and ...
Tuberculosis (TB) remains a global health challenge, affecting millions each year. In 2023, an estimated 10.8 million people contracted TB, with 1.25 million deaths, according to the World Health ...
Mumbai: Over 1,000 patients with drug-resistant tuberculosis in Mumbai started a new drug combination that reduced the ...
Tuberculosis (TB) is the world's deadliest infectious disease—and one of the hardest to cure. Standard treatment requires a cocktail of multiple drugs over at least six months, and one in five ...
The approval significantly strengthens Delhi’s ability to diagnose multidrug-resistant (MDR-TB) and drug-resistant ...
TB is an infectious disease that is far from being eradicated and controlled. The treatment for TB is associated with noncompliance to therapy because it consists of a long-term treatment with a ...
Reports of TB date back to around 410-400 B.C.E., when the physician Hippocrates termed the disease phthisis, an archaic word that means a progressive “wasting away,” due to the way people with the ...
A new study uncovers vulnerabilities in drug-resistant TB, offering hope for improved treatments. Rutgers Health research has uncovered why a relatively new antibiotic for tuberculosis (TB) works ...
An international research team headed by scientists at the University of British Columbia has demonstrated how a novel semi-synthetic compound derived from sanguinarine (SG), an alkaloid extracted ...
A TB patient receiving counseling and treatment at Kerugoya Hospital TB Management Center. [Jane Mugambi, Standard] African countries should increase their investment in Tuberculosis and especially in ...
We talked to experts in obesity, tobacco, AI, HIV, TB and the NHI to find out what we can expect — and what we can’t — this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback